Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael T Heneka

Showing results (51-60 of 313) with videos related to

Pageof 32
Sort By:
Nature Reviews. Immunology|June 26, 2014
Innate immune activation in neurodegenerative diseaseMichael T Heneka, Markus P Kummer, Eicke Latz
Nature Clinical Practice. Neurology|September 7, 2007
Drug insight: effects mediated by peroxisome proliferator-activated receptor-gamma in CNS disordersMichael T Heneka, Gary E Landreth, Michael Hüll
Nature Reviews. Neuroscience|February 12, 2019
Author Correction: Inflammasome signalling in brain function and neurodegenerative diseaseMichael T Heneka, Róisín M McManus, Eicke Latz
Brain Research Reviews|December 1, 2009
Neuroglia in neurodegenerationMichael T Heneka, José J Rodríguez, Alexei Verkhratsky
Brain : a Journal of Neurology|January 8, 2025
Zooming in on brain inflammation in Alzheimer's diseaseWiesje M van der Flier, Michael T Heneka
Annual Review of Medicine|November 7, 2017
Innate Immunity and NeurodegenerationLarisa I Labzin, Michael T Heneka, Eicke Latz
Nature Immunology|February 18, 2015
Innate immunity in Alzheimer's diseaseMichael T Heneka, Douglas T Golenbock, Eicke Latz
The Lancet. Oncology|July 3, 2004
Antineoplastic effects of peroxisome proliferator-activated receptor gamma agonistsChristian Grommes, Gary E Landreth, Michael T Heneka
Nature Reviews. Neuroscience|September 13, 2018
Inflammasome signalling in brain function and neurodegenerative diseaseMichael T Heneka, Róisín M McManus, Eicke Latz
Molecular Neurobiology|February 26, 2014
Body fluid cytokine levels in mild cognitive impairment and Alzheimer's disease: a comparative overviewFrederic Brosseron, Marius Krauthausen, Markus Kummer, et al.
Pageof 32

Showing results (51-60 of 313) with videos related to

Sort By:
Pageof 32
Nature Reviews. Immunology|June 26, 2014
Innate immune activation in neurodegenerative diseaseMichael T Heneka, Markus P Kummer, Eicke Latz
Nature Clinical Practice. Neurology|September 7, 2007
Drug insight: effects mediated by peroxisome proliferator-activated receptor-gamma in CNS disordersMichael T Heneka, Gary E Landreth, Michael Hüll
Nature Reviews. Neuroscience|February 12, 2019
Author Correction: Inflammasome signalling in brain function and neurodegenerative diseaseMichael T Heneka, Róisín M McManus, Eicke Latz
Brain Research Reviews|December 1, 2009
Neuroglia in neurodegenerationMichael T Heneka, José J Rodríguez, Alexei Verkhratsky
Brain : a Journal of Neurology|January 8, 2025
Zooming in on brain inflammation in Alzheimer's diseaseWiesje M van der Flier, Michael T Heneka
Annual Review of Medicine|November 7, 2017
Innate Immunity and NeurodegenerationLarisa I Labzin, Michael T Heneka, Eicke Latz
Nature Immunology|February 18, 2015
Innate immunity in Alzheimer's diseaseMichael T Heneka, Douglas T Golenbock, Eicke Latz
The Lancet. Oncology|July 3, 2004
Antineoplastic effects of peroxisome proliferator-activated receptor gamma agonistsChristian Grommes, Gary E Landreth, Michael T Heneka
Nature Reviews. Neuroscience|September 13, 2018
Inflammasome signalling in brain function and neurodegenerative diseaseMichael T Heneka, Róisín M McManus, Eicke Latz
Molecular Neurobiology|February 26, 2014
Body fluid cytokine levels in mild cognitive impairment and Alzheimer's disease: a comparative overviewFrederic Brosseron, Marius Krauthausen, Markus Kummer, et al.
Pageof 32